RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

Clinical trial NCT06146101 · COMPLETED

Trial details

NCT number: NCT06146101
Sponsor: Incannex Healthcare Ltd
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Obstructive Sleep Apnea

Start date: 2024-05-02
Primary completion: 2025-05-20
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.